Search
for
Sort by
Research 331–360 of 432
- The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF)
- The prevalence of itch and pain and its characteristics in patients with mild to moderate insufficiency and its relationship to the degree of venous insufficiency
- The use of diphencyprone in dermatology: A retospective audit
- Their year at Parkland Memorial Hospital (2005)
- HAIR AND SYSTEMATIC DISEASE
- Secondary cicatricial and other permanent alopecias
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Clinical Case Notes. Retinoblastoma, microphthalmia and the chromosome 13q deletion syndrome
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Perspectives on Dermatopathology
- Assessment of ameliorative potential of Aegle marmelos fruit extract against hematological and biochemical alterations in sub-acute arsenic toxicity in mice
- Table of Contents
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- ALLETHRIN INDUCED TOXICOPATHOLOGICAL ALTERATIONS IN ADULT MALE ALBINO RATS
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Adult Group B Streptococcal Disease
- Microneedles as a perspective for transdermal therapeutic systems
- The Molecular Basis of Blood Diseases
- Assessment of the tolerability and efficacy of supplementation containing micronized and emulsified ferric pyrophosphate in patients with iron deficiency — an observational study
- Quantitation of Hepatitis C Virus RNA
- Diagnosing Vascular Causes of Renal Failure
- Liver Cirrhosis and Circadian Rhythm
- Disorders of Hair Growth: Diagnosis and Treatment
- Fighting for Life: American Military Medicine in World War II
- Vitamins
- Impact of Iron Deficiency on the Individual
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- Reversal of male-pattern baldness, hypertrichosis, and accelerated hair and nail growth in patients receiving benoxaprofen.